Latest From Biotech Now

How the Orphan Drug Tax Credit Leverages MDA’s Fight against Rare Genetic Diseases

dna_peoplefigures

In the early 1950s, a small group of concerned parents, people with muscular dystrophy and their friends started a volunteer organization, the Muscular Dystrophy Association (MDA), to raise money for research into the causes of rare genetic diseases that mysteriously destroyed muscles and shortened lives. In the decades since — thanks to the support of a caring public and vital corporate partnerships — MDA has become a leading voluntary health agency, funding research in academic Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Amid Doping Scandals, Industry Must Remain Vigilant

track

As doping in sport makes its way back into the news of the day, we must consider the consequences beyond undermining the integrity and honor of sports and competition. Doping undermines the integrity of our industry’s core mission of serving patients through drug discovery and development. Biologic products intended for use as medicines can enhance endurance, minimize recovery time, or promote muscle growth. The same medicines that can be used to help children with devastating Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Jobs: The Talent Hub for Biotechnology

Jim Greenwood

The Biotechnology Industry Organization is proud to launch BIO Jobs, an online career resource where you can find the industry’s leading biotechnology employment opportunities all in one place. Visit jobs.bio.org to: Search for and quickly apply to a variety of positions available worldwide Set up job alerts so you are immediately notified any time a job is posted that matches your skills or interests Create an anonymous job seeker profile or upload your resume anonymously Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

TPP and Innovation in the Bioeconomy: The Need for 12 Years of Data Protection

BIO Logo Horizontal 4C copy

A few weeks ago, BIO submitted a letter and white paper (PDF) to the U.S. Trade Representative outlining recommendations for policies to pursue with TPP negotiating partners to ensure intellectual property protection for innovative biologic products. Standards that enable biotechnology companies to protect and leverage their intellectual property are of critical importance to companies seeking breakthrough treatments and cures for patients in need worldwide. Implementing standards of protection that effectively protect innovation for biological products within the TPP region Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

How Do Patients Get Their Medicines During Hurricanes?

hurricane-season-hurricane-earl-2010-1024x576-940x198

Hurricane season has grown to last six months – running June through November. This means we are well into 2013′s hurricane season. Although the Eastern and Southern United States have seen their fair share of bad storms in the last few years, the most recent major hurricane to strike the U.S. was Hurricane Wilma in 2005. Surprisingly Hurricane Sandy in October of 2012 was not technically was not a hurricane, but a confluence of major Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,